Non-medical Treatment for Patients Living with Epilepsy: What Happens When Everything Else Fails —
Monday, January 19, 2009 - 12 noon (EST)
Epilepsy is the third most common neurological disorder in the United States after Alzheimer's disease and stroke. It is equal in prevalence to cerebral palsy, multiple sclerosis and Parkinson's disease combined. It is estimated that epilepsy and seizures affect over 3 million Americans of all ages, and approximately 200,000 new cases of seizures and epilepsy occur each year.
Dr. Imad Michel Najm, the Director of Cleveland Clinic Epilepsy Center, has been with Cleveland Clinic since 1997 in the Department of Neurology. He serves as the Head, Section of Adult Epilepsy and Clinical Neurophysiology. Dr. Najm received his medical degree from St. Joseph University Faculty of Medicine in Beirut. His post-doctoral research training was at the University of California-Irvine and the University of Southern California focusing on the molecular mechanisms of epilepsy. He completed a clinical residency in neurology and a fellowship in epilepsy and clinical neurophysiology at Cleveland Clinic.
Dr. Najm leads a multidisciplinary team in the Epilepsy Center with a comprehensive range of skills and knowledge. State-of-the-art diagnostic capabilities, extensive medical and surgical treatment programs and an active research focus that has yielded important basic and clinical science contributions have made the Cleveland Clinic Epilepsy Center a place of national and international prominence as a leading facility for the management and investigation of epilepsy. The Cleveland Clinic Epilepsy Center is a place of national and international prominence as a leading facility for the management and investigation of epilepsy. Each year the Epilepsy Center staff members see more than 4,000 adults and 2,000 pediatric patients and perform more than 200 surgical procedures. The Epilepsy Center also uses the most advanced invasive and noninvasive technology available to localize the epileptic focus and develop a targeted treatment plan.
This Health Chat will open on January 16, 2009 to allow you to submit questions. We will try to answer as many questions as possible during the chat. Please create an account to attend the chat and submit your questions.








